伝統的知恵と現代科学: 潰瘍性大腸炎のモデルにおけるサンフアンシュアイの保護的役割
Nianchao Zhang1, Amei Liu1, Mingyue Cao1
1Institute of Basic Medicine, North Sichuan Medical College, Nanchong, Sichuan Province, 637100, PR China; Nanchong Key Laboratory of Metabolic Drugs and Biological Products, 55 Dongshun Road, Nanchong, 637100, PR China.
まとめ
サンフアンシュウ
科学分野:
- 胃腸内科
- 薬理学について
- 細胞生物学
背景:
- 潰瘍性大腸炎 (UC) の病原性は完全に理解されていません.
- サンフアン・シュアイ・デコクション (SSD) は,炎症状態の可能性を示しています.
- UCモデルにおけるSSDの保護メカニズムについては,説明が必要である.
研究 の 目的:
- UCモデルにおけるSSDの保護効果を調査する.
- SSDが表皮壁の整体性と炎症に与える影響を検証する.
- オートファギーとミトファギーのメカニズム的な役割を明らかにする.
主な方法:
- LPS誘発ヒト大腸オルガノイドとDSS誘発マウスモデルを使用した.
- 細胞の生存能力,上皮の壁の整体性,および組織学的評価
- オートファジーとミトファジー経路に関するメカニズム的研究を行った.
主要な成果:
- SSD治療は,細胞の生存能力と上皮壁の整合性を強化した.
- SSDは組織形態を改善し,炎症を軽減し,体内皮質の完全性を回復させた.
- SSDはPIP4K2C経由でオートファギーを調節し,ウォゴニン-PIP4K2C-PINK1シグナリング経由でミトファギーを促進した.
結論:
- SSDは腸壁機能を強化し,炎症を軽減することによってUCの症状を軽減します.
- このメカニズムは,PINK1/PARKINシグナリングを活性化する,ウゴニン-PIP4K2C-PINK1複合体の形成を伴う.
- SSDはミトコンドリアのオートファギーを促進し,腸の障壁を修復し,UCのための新しい治療目標を提供します.
関連する概念動画
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
684
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
684
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
523
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
523
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
01:26Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145